peptide 140 Alzheimer's disease is linked to amyloid β (Aβ) peptide aggregation - peptide-therapy-plantation 140 Understanding Peptide 140: A Multifaceted Molecule in Research and Therapeutics

peptide-therapy-peachtree-city The term "peptide 140" encompasses a diverse range of molecules, each with unique properties and potential applications.Chemoselective Peptide Modification via Photocatalytic ... While the number "140" itself might seem arbitrary, it often refers to a specific position within a larger protein or a sequence length, giving rise to distinct peptides with significant roles in biological research and the development of novel therapeutics. This exploration delves into the various facets of peptide 140, drawing from scientific literature and research findings to provide a comprehensive overview.

One prominent example is the P140 peptide, which has garnered attention for its immunomodulatory capabilities. Research indicates that P140 acts by depleting hyper-activated autoreactive T and B cells, thereby restoring normal immune homeostasis. This mechanism suggests potential applications in treating autoimmune diseases. Further studies on the P140 peptide have demonstrated its ability to increase lymphocyte apoptosis in models like MRL/lpr mice and decrease autoepitope recognition by T cellsThe therapeutic P140 peptide, a new immunomodulating .... The P140 peptide is not a naturally occurring entity but rather a synthetic molecule derived from the U1-70K protein. It is specifically modified to contain a phosphoserine residue at position 140 and binds to the HSPA8/HSC70 chaperone protein.

Beyond its role in autoimmunity, peptide 140 variations appear in other significant biological contexts. For instance, the Myelin proteolipid protein 140-152 is an epitope peptide utilized for antigen-specific stimulation of T-cells, crucial in understanding neurological conditionsHBV core protein (128-140). Similarly, HBV core protein (128-140) and HBV Core Protein [128-140] Peptide are derived from the Hepatitis B Virus and are recognized as MHC class II pan T helper peptides.CRAMP (140-173) (mouse) (trifluoroacetate salt) In the realm of oncology, the BKT-140 peptide has been explored in conjunction with modified polymer micelles for treating tumor metastasis, showcasing enhanced cell internalization.

The number 140 also appears in sequences related to viral research, such as HCV Peptide (131-140), used in the study of the hepatitis C virus. In the context of HIV research, PRO 140 has been investigated, with studies exploring the addition of short fusion-inhibitory peptides to enhance its activity in inhibiting viral entry. The T-140 analog peptides are another area of interest, with potential therapeutic uses and compositions being patented. T 140 itself is described as a high-affinity CXCR4 peptide antagonist, known for its ability to mobilize stem cells and inhibit growth.

Furthermore, certain peptide 140 sequences are associated with neurodegenerative diseases. Alpha-Synuclein (α-Synuclein), 96-140 is a fragment of a protein found in Parkinson's Disease aggregates. The broader field of Alzheimer's disease is linked to amyloid β (Aβ) peptide aggregation in the brain, highlighting the importance of understanding peptide behavior in neurological disorders.

The research into peptide 140 also extends to broader applications in immunotherapy. For example, strategies for deeply downregulating PD-L1 in tumor cells involve caged peptides that activate the immune system for effective immunotherapy. The development of 140 peptide therapeutics is an active area, with some already being evaluated in clinical trials160926-86-3 | Product Name : HCV Peptide (131-140). This indicates a growing interest in leveraging the specific properties of peptides for medical interventions.

In summary, the term peptide 140 represents a significant area of scientific inquiry. From its role in modulating the immune system and fighting autoimmune diseases (like the P140 peptide), to its involvement in viral research (e.g., HCV Peptide (131-140)), oncology (BKT-140 peptide), and neurodegenerative conditions (Alpha-Synuclein, 96-140), these molecules hold immense promise. The ongoing research, including the evaluation of 140 peptide therapeutics in clinical trials, underscores the expanding potential of peptide science in advancing human health. The ability to synthesize specific peptides, such as Research-grade Sp140 Blocking Peptide, further enables detailed investigations into their biological functions and therapeutic applicationsP140 Peptide Leads to Clearance of Autoreactive .... The exploration of peptides in various scientific disciplines continues to uncover new possibilities for diagnosis, treatment, and fundamental biological understandingT 140 - an overview.